1. Formula feed preparation: helping reduce the risks; a systematic review. Issue 10 (19th September 2003) Authors: Renfrew, M J; Ansell, P; Macleod, K L Journal: Archives of disease in childhood Issue: Volume 88:Issue 10(2003) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Health of children born to medical radiographers. Issue 2 (February 1996) Authors: Roman, E; Doyle, P; Ansell, P; Bull, D; Beral, V Journal: Occupational and environmental medicine Issue: Volume 53:Issue 2(1996) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS1.2 Stability of EGFR amplification in glioblastoma is differentially impacted based on therapeutic pressure. (19th September 2018) Authors: Ahluwalia, M; Narita, Y; Muragaki, Y; Gan, H; Merrell, R; van den Bent, M; Roberts-Rapp, L; Guseva, M; Ansell, P; Lassman, A Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P01.052 Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux -M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406). (19th September 2018) Authors: van den Bent, M; French, P; Eoli, M; Sepulvado, J; Walenkamp, A; Weller, M; Looman, J; Ansell, P; Gorlia, T; Golfinopoulos, V Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P01.066 Patients with EGFR amplification but without EGFRvIII expression have improved benefit compared to those with EGFRvIII expression in samples of the INTELLANCE 2/EORTC 1410 randomized phase II trial. (19th September 2018) Authors: French, P J; Kros, J; de Heer, I; Ansell, P; Looman, J; Bain, E; Morfouace, M; Gorlia, T; Golfinopoulos, V; van den Bent, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P11.08 Defining EGFR amplification status for clinical trial inclusion. (6th September 2019) Authors: French, P; Eoli, M; Sepulveda, J; de Heer, I; Kros, J M; Walenkamp, A; Frenel, J; Franceschi, E; Clement, P; Weller, M; Ansell, P; Looman, J; Bain, E; Morfouace, M; Gorlia, T; van den Bent, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗